Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AGRX | RDY | TEVA | BHC | BBIO |
| Company | Agile Therapeutics Inc | Dr. Reddy's Laboratories Ltd ADR | Teva Pharmaceutical Industries ADR | Bausch Health Companies Inc | Bridgebio Pharma Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NYSE | NASDAQ |
| Open | 0.3610 | 71.43 | 12.98 | 8.54 | 25.37 |
| High | 0.3808 | 71.63 | 13.09 | 8.59 | 25.78 |
| Low | 0.3610 | 71.15 | 12.89 | 8.45 | 24.91 |
| Last | 0.3808 | 71.29 | 13.02 | 8.50 | 24.95 |
| Change | +0.0108 | -0.20 | +0.01 | -0.03 | -0.51 |
| % Change | +2.92% | -0.28% | +0.08% | -0.35% | -2.00% |
| Volume | 14,176 | 23,239 | 2,396,249 | 306,350 | 193,525 |
| 20-Day Average Volume | 149,924 | 156,485 | 8,754,823 | 4,113,324 | 1,540,480 |
| Previous Close | 0.3700 | 71.49 | 13.01 | 8.53 | 25.46 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3515 | 72.43 | 13.59 | 9.33 | 27.32 |
| 20-Day Raw Stochastic | 80.12% | 18.52% | 25.32% | 5.32% | 12.33% |
| 20-Day Relative Strength | 37.20% | 43.15% | 44.92% | 41.35% | 36.02% |
| Weighted Alpha | -92.33 | +16.10 | +54.68 | +0.25 | -6.94 |
| Today's Opinion | 88% Sell | 24% Buy | 56% Buy | 40% Buy | 88% Sell |
| Previous Opinion | 88% Sell | 24% Buy | 56% Buy | 48% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 56% Buy | 100% Buy | 88% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.53% since 04/17/24 | +0.13% since 04/17/24 | -1.33% since 04/17/24 | -1.56% since 04/17/24 | +0.12% since 04/17/24 |
| Low | 0.3610 on 04/24/24 | 70.71 on 04/19/24 | 12.51 on 04/19/24 | 8.42 on 04/22/24 | 24.14 on 04/22/24 |
| High | 0.4000 on 04/23/24 | 72.23 on 04/22/24 | 13.21 on 04/18/24 | 8.80 on 04/22/24 | 26.26 on 04/23/24 |
| 1-Month | |||||
| %Chg | -30.37% since 03/22/24 | -2.82% since 03/22/24 | -6.37% since 03/22/24 | -10.83% since 03/22/24 | -15.45% since 03/22/24 |
| Low | 0.2000 on 03/26/24 | 70.71 on 04/19/24 | 12.51 on 04/19/24 | 8.36 on 04/11/24 | 24.14 on 04/22/24 |
| High | 0.6111 on 03/25/24 | 74.44 on 04/01/24 | 14.47 on 04/08/24 | 11.46 on 04/03/24 | 31.23 on 03/27/24 |
| 3-Month | |||||
| %Chg | -76.05% since 01/24/24 | +1.51% since 01/24/24 | +8.65% since 01/24/24 | +6.03% since 01/24/24 | -30.99% since 01/24/24 |
| Low | 0.2000 on 03/26/24 | 69.18 on 01/25/24 | 11.48 on 01/30/24 | 7.68 on 02/05/24 | 24.14 on 04/22/24 |
| High | 1.6600 on 01/30/24 | 77.72 on 02/23/24 | 14.47 on 04/08/24 | 11.46 on 04/03/24 | 41.04 on 02/15/24 |
| 6-Month | |||||
| %Chg | -79.96% since 10/24/23 | +6.93% since 10/24/23 | +58.79% since 10/24/23 | +19.23% since 10/24/23 | -0.24% since 10/24/23 |
| Low | 0.2000 on 03/26/24 | 63.72 on 11/03/23 | 8.10 on 10/27/23 | 6.53 on 11/13/23 | 24.12 on 10/25/23 |
| High | 2.6063 on 12/04/23 | 77.72 on 02/23/24 | 14.47 on 04/08/24 | 11.46 on 04/03/24 | 44.32 on 12/28/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,537 | 11,930,109 | 14,585,432 | 3,116,964 | 4,476,683 |
| Shares Outstanding, K | 6,856 | 166,878 | 1,121,094 | 365,412 | 175,832 |
| Annual Sales | 19,590,000 | 2,992,000,000 | 15,846,000,000 | 8,757,000,000 | 9,300,000 |
| Annual Net Income | -14,470,000 | 548,000,000 | -559,000,000 | -592,000,000 | -643,200,000 |
| Last Quarter Sales | 3,620,000 | 865,780,000 | 4,457,000,000 | 2,408,000,000 | 1,750,000 |
| Last Quarter Net Income | -4,470,000 | 165,470,000 | 429,000,000 | -39,000,000 | -168,150,000 |
| 60-Month Beta | 1.42 | 0.58 | 1.05 | 0.85 | 1.03 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.46 on 03/28/24 | 0.99 on 01/31/24 | 1.00 on 01/31/24 | 1.15 on 02/22/24 | -0.96 on 02/22/24 |
| Latest Earnings Date | 05/09/24 | 05/08/24 | 05/08/24 | 05/02/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.410 on 07/28/23 | 0.072 on 11/27/17 | 1.000 on 11/10/10 | N/A |
| Next Ex-Dividends Date | N/A | 07/28/23 | 11/27/17 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.04 | 5.21 | 2.41 | 0.00 |